ChiCTR2300073513 版本V1.1 版本创建时间2023/09/07 10:16:24 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2300073513 

最近更新日期:

Date of Last Refreshed on:

2023-07-13 08:39:12 

注册时间:

Date of Registration:

2023-07-13 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

预测法洛四联症患儿液体反应性的肝脏按压试验

Public title:

Liver compression test for predicting fluid responsiveness in children with Tetralogy of Fallot

注册题目简写:

English Acronym:

研究课题的正式科学名称:

预测法洛四联症患儿液体反应性的肝脏按压试验

Scientific title:

Liver compression test for predicting fluid responsiveness in children with Tetralogy of Fallot

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

刘婷 

研究负责人:

孙瑛 

Applicant:

Ting LIU 

Study leader:

Ying Sun 

申请注册联系人电话:

Applicant telephone:

+86 180 2106 0798

研究负责人电话:

Study leader's telephone:

+86 136 2173 8118

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

tinga277@163.com

研究负责人电子邮件:

Study leader's E-mail:

yingsun821@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

上海市浦东新区东方路1678号

研究负责人通讯地址:

上海市浦东新区东方路1678号

Applicant address:

1678 Dongfang Road, Pudong New District, Shanghai, China

Study leader's address:

1678 Dongfang Road, Pudong New District, Shanghai, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

上海儿童医学中心麻醉科

Applicant's institution:

Department of Anesthesiology, Shanghai Children's Medical Center

研究负责人所在单位:

上海儿童医学中心麻醉科

Affiliation of the Leader:

Department of Anesthesiology, Shanghai Children's Medical Center

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

SCMCIRB-K2023098-1

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

上海儿童医学中心伦理委员会

Name of the ethic committee:

Shanghai Children's Medical Center Ethics Committee

伦理委员会批准日期:

Date of approved by ethic committee:

2023-06-16 00:00:00

伦理委员会联系人:

徐卓明

Contact Name of the ethic committee:

Zhuo-Ming Xu

伦理委员会联系地址:

上海市浦东新区东方路1678号

Contact Address of the ethic committee:

1678 Dongfang Road, Pudong New District, Shanghai, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 21 3862 6161

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

上海儿童医学中心

Primary sponsor:

Shanghai Children's Medical Center

研究实施负责(组长)单位地址:

上海市浦东新区东方路1678号

Primary sponsor's address:

1678 Dongfang Road, Pudong New District, Shanghai, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

上海

市(区县):

上海

Country:

China

Province:

Shanghai

City:

Shanghai

单位(医院):

上海交通大学附属上海儿童医学中心

具体地址:

上海市浦东新区东方路1678号

Institution
hospital:

Shanghai Children's Medical Center

Address:

1678 Dongfang Road, Pudong New District

经费或物资来源:

Source(s) of funding:

None

Target disease:

scheduled for elective surgery under general anesthesia

Target disease code:

研究类型:

诊断试验

Study type:

Diagnostic test

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

析因分组(即根据危险因素或暴露因素分组) 

Study design:

Factorial 

研究目的:

本研究目的是评估在法洛四联症儿童群体中,使用肝脏压迫试验引起的血流动力学动态指标的变化能否预测液体反应性。  

Objectives of Study:

The purpose of this study was to evaluate whether changes in hemodynamic dynamic parameters induced by liver compression test could predict fluid responsiveness in pediatric with Tetralogy of Fallot.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

(1) 年龄1~5岁。 (2) 计划接受法洛四联症手术的小儿患者 (3) 有创动脉血压。 (4) 得到父母或者监护人的允许(签署知情同意书)。

Inclusion criteria

(1) Age 1-5 years old. (2) Children who plan to undergo surgery for Tetralogy of Fallot (3) Invasive arterial blood pressure. (4) Obtain permission from parents or guardians (sign informed consent form)

排除标准:

(1) 术前心律失常。 (2) 明显的肝、肾或肺疾病。 (3) 血流动力学不稳定。 (4) 父母或者患儿法定监护人拒绝。

Exclusion criteria:

(1) Preoperative arrhythmia. (2) Obvious liver, kidney, or lung disease. (3) Hemodynamic instability. (4) The parents or the child's Legal guardian refused.

研究实施时间:

Study execute time:

From 2023-07-13 00:00:00 To 2024-07-20 00:00:00  

征募观察对象时间:

Recruiting time:

From 2023-07-13 00:00:00 To 2024-07-20 00:00:00  

诊断试验:

Diagnostic Tests:

金标准或参考标准(即可准确诊断某疾病的单项方法或多项联合方法,在本研究中用于诊断是否有该病的临床参考标准):

临床结局(肝脏压迫引起的血流动力学参数变化,如PVI、SVV、SV、MAP、PPV等指标的变化)

Gold Standard or Reference Standard (The clinical reference standards required to establish the presence or absence of the target condition in the tested population in present study):

Clinical outcome(Changes in hemodynamic parameters caused by liver compression test, such as changes in indicators, PVI ,SVV, SV, MAP, PPV, etc.)

指标试验(即本研究的待评估诊断试验,无论为方法、生物标志物或设备,均请列出名称):

在法洛四联症患者群体中使用肝脏压迫试验引起的血流动力学改变

Index test:

Hemodynamic changes caused by the use of liver compression test in a population of patients with Tetralogy of Fallot

目标人群(可以是某种疾病患者或正常人群,详细描述其疾病特征,注意应纳入符合分布特点的全序列病例,具有良好的代表性)

择期全麻下行法洛四联症手术的患儿(液体反应组和液体无反应组)

例数:

Sample size:

37

Target condition (The target condition is a particular disease or disease stage that the index test will be intended to identify. Please specify the characteristics in detail; the population should has a complete spectrum and good representative):

Children undergoing surgery for Tetralogy of Fallot under selective general anesthesia (fluid responders group and fluid non responders group)

容易混淆的疾病人群(即与目标疾病不易区分的一种或多种不同疾病,应避免采用正常人群对照的病例-对照设计):

例数:

Sample size:

0

Population with condition difficult to distinguish from the target condition, the normal population in a case-control study design should be avoid:

None

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

上海 

市(区县):

上海 

Country:

China 

Province:

shanghai 

City:

 

单位(医院):

上海儿童医学中心 

单位级别:

三级甲等 

Institution
hospital:

Shanghai Children's Medical Center

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

灌注变异指数

指标类型:

主要指标

Outcome:

pleth variability index

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

脉压变异度

指标类型:

主要指标

Outcome:

pulse pressure variation

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

心率

指标类型:

次要指标

Outcome:

heart rate

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

收缩压

指标类型:

次要指标

Outcome:

systolic blood pressure

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

每搏量

指标类型:

主要指标

Outcome:

stroke volume

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

每搏变异度

指标类型:

主要指标

Outcome:

stroke volume variation

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

心脏指数

指标类型:

主要指标

Outcome:

cardiac index

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

舒张压

指标类型:

次要指标

Outcome:

diastolic blood pressure

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

无采集人体标本

组织:

Sample Name:

No collection of human specimens

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 1 years
最大 Max age 5 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

不适用

Randomization Procedure (please state who generates the random number sequence and by what method):

N/A

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

N/A

Blinding:

N/A

是否共享原始数据:

IPD sharing

No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

发表后6个月内,上传至期刊 请阅读网页注册指南中关于 原始数据共享 的内容。

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

6 months after publication, submit to journal

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表和Excel表格

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form and Excel

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2023-07-13 08:38:31